DETERMINATION OF PATIENTS ADHERANCE TO BETABLOCKERS AFTER MYOCARDIAL INFARCTION DISCHARGE
Mohammad Arief*, Syed Aziz Ghori, Shaik Irfan Pasha, Sheik Mudassar
Abstract
Beta-blockers, which are considered as one of the most important
drugs in the secondary prevention of AMI, were underutilized by many
patients over the world, though there is no absolute contraindication.
Though the outcome of various studies showed that the use of betablockers
in post –MI patients with mild COPD, Asthma, Diabetes may
also get benefited but still the usage is less. In view of this our study
mainly aims to determine whether the patients are in compliance with
their prescriptions or not. It also targets how to improve the adherence
of patients to the prescription drugs. The present study is an
observational, prospective, non-interventional in which data on 320
patients surviving acute- MI over 8 months was collected, at KIMS
hospital. Among 320, 205 discharged with prescription on beta-blocker and 115 without a
prescription on beta-blockers. Out of 205 patients, only 160 prescriptions were received
during the first 30 days after discharge. This number had declined to 92, 84 after 120 and 240
days respectively. The decreased number of prescriptions was also seen in patients who were
not discharged on beta-blockers; initially 115 prescriptions were received during the first 30
days, followed by 103, 96 after 120 and 240 days respectively. Our study mainly concludes
that along with appropriate dosing and monitoring, patient education is essential to maximize
efficacy of therapy, moreover the decreased usage of beta-blockers in post-MI patients
indicates the need of pharmacist intervention for the regular use of beta-blockers by patients
for secondary prevention of AMI.
Keywords: Acute Myocardial Infarction, beta-blocker therapy, Chronic Obstructive Pulmonary Disease, Asthma, Non-interventional study.
[Full Text Article]